The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
Open accessAbstract
Summary Immune system regulation is of paramount importance to host survival. In settings of autoimmunity and alloimmunity, control is lost, resulting in injury to vital organs and tissues. Naturally occurring, thymic-derived T regulatory cells (Tregs) that express CD4, CD25 and the forkhead box protein 3 (FoxP3) are potent suppressors of these adverse immune responses. Preclinical studies have shown that either freshly isolated or ex vivo expanded Tregs can prevent both local and systemic organ and tissue destruction. Although promising, human Treg infusion therapy has heretofore been difficult to implement in the clinic, and relatively few clinical trials have been initiated. This review will focus on the preclinical models that provide the rationale for current trials and it will address both the challenges and opportunities in human Treg therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Radhakrishnan, S., Cabrera, R., Schenk, E. L., Nava-Parada, P., Bell, M. P., Keulen, V. P. V., Marler, R. J., Felts, S. J., & Pease, L. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3137 · Cited by 119
RetractedControl of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 2×
“Thispoint wasmostdramatically illustrated ina phase I clinical trial testing TGN1412, a superagonistic CD28 antibody (Ab) (Suntharalingam et al., 2006).”
BackgroundCD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,826
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,641
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
van Meerbeeck, J. P., Fennell, D. A., & De Ruysscher, D. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60165-7 · Cited by 1,237
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.007 · Cited by 1,136
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Battaglia, M., Stabilini, A., & Roncarolo, M.-G. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,134
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113 · cited 1×
“Nonobese diabetic (NOD) mice spontaneously acquire T1D and they have been the workhorse for murine studies of Treg cells and T1D progression (Anderson and Bluestone, 2005).”
BackgroundHoffmann, P., Ermann, J., Edinger, M., Fathman, C. G., & Strober, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020399 · Cited by 1,098
Hori, S., Nomura, T., & Sakaguchi, S. (2017) · The Journal of Immunology · doi:10.1093/jimmunol/198.3.981 · Cited by 1,066
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.002 · Cited by 1,055
Taylor, P. A., Lees, C. J., & Blazar, B. R. (2002) · Blood · doi:10.1182/blood.v99.10.3493 · Cited by 1,041
Self-citationHumanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Tang, Q., & Bluestone, J. A. (2008) · Nature Immunology · doi:10.1038/ni1572 · Cited by 1,031
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Benson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1326 · Cited by 835
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 766
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
CD4+CD25+ Immunoregulatory T Cells
Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D., & Salomon, B. L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020090 · Cited by 687
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylation
Kim, H.-P., & Leonard, W. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070109 · Cited by 597
Valencia, X., Yarboro, C., Illei, G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 594
The NOD mouse model of type 1 diabetes: As good as it gets?
Atkinson, M. A., & Leiter, E. H. (1999) · Nature Medicine · doi:10.1038/9442 · Cited by 588
Taylor, P. A., Noelle, R. J., & Blazar, B. R. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1311 · Cited by 575
Self-citationControl of Regulatory T Cell Lineage Commitment and Maintenance
Josefowicz, S. Z., & Rudensky, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.009 · Cited by 571
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Shevach, E. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.003 · Cited by 549
Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L., Qin, F. X.-F., Gilliet, M., & Liu, Y.-J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.018 · Cited by 539
Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H., & Hori, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811556106 · Cited by 523
Gene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Self-citationTrenado, A., Charlotte, F., Fisson, S., Yagello, M., Klatzmann, D., Salomon, B. L., & Cohen, J. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17702 · Cited by 495
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R., & Edinger, M. (2004) · Blood · doi:10.1182/blood-2004-01-0086 · Cited by 494
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debré, P., Piette, J.-C., & Gorochov, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8392 · Cited by 456
Chen, W., Liang, X., Peterson, A. J., Munn, D. H., & Blazar, B. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5396 · Cited by 453
Self-citationHaas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Directed evolution of human T-cell receptors with picomolar affinities by phage display
Li, Y., Moysey, R., Molloy, P. E., Vuidepot, A.-L., Mahon, T., Baston, E., Dunn, S., Liddy, N., Jacob, J., Jakobsen, B. K., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1070 · Cited by 442
The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure
Roep, B. O. (2003) · Diabetologia · doi:10.1007/s00125-003-1089-5 · Cited by 431
Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispin, J. C., Martı́nez, A., & Alcocer-Varela, J. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00121-5 · Cited by 408
Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R., & Edinger, M. (2006) · Blood · doi:10.1182/blood-2006-06-027409 · Cited by 407
Organ transplantation—how much of the promise has been realized?
Lechler, R. I., Sykes, M., Thomson, A. W., & Turka, L. A. (2005) · Nature Medicine · doi:10.1038/nm1251 · Cited by 390
Szanya, V., Ermann, J., Taylor, C., Holness, C., & Fathman, C. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2461 · Cited by 373
Decreased FOXP3 levels in multiple sclerosis patients
Huan, J., Culbertson, N., Spencer, L., Bartholomew, R., Burrows, G. G., Chou, Y. K., Bourdette, D., Ziegler, S. F., Offner, H., & Vandenbark, A. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20522 · Cited by 369
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Putnam, A. L., Brusko, T. M., Lee, M. R., Liu, W., Szot, G. L., Ghosh, T., Atkinson, M. A., & Bluestone, J. A. (2009) · Diabetes · doi:10.2337/db08-1168 · Cited by 357
Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., Lucas, P. J., Gress, R. E., Levine, B. L., June, C. H., Serody, J. S., & Blazar, B. R. (2004) · Blood · doi:10.1182/blood-2004-05-1850 · Cited by 351
Self-citationRegulatory T-cell compartmentalization and trafficking
Wei, S., Kryczek, I., & Zou, W. (2006) · Blood · doi:10.1182/blood-2006-01-0177 · Cited by 346
Tarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S., & Steinman, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061631 · Cited by 342
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Self-citationDefects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
Flores-Borja, F., Jury, E. C., Mauri, C., & Ehrenstein, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806855105 · Cited by 312
Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7350 · Cited by 301
Hall, B. M., Pearce, N. W., Gurley, K. E., & Dorsch, S. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.141 · Cited by 298
Godfrey, W. R., Spoden, D. J., Ge, Y. G., Baker, S. R., Liu, B., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2005) · Blood · doi:10.1182/blood-2004-06-2467 · Cited by 297
Self-citationOlivares-Villagómez, D., Wang, Y., & Lafaille, J. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1883 · Cited by 294
Cellular Basis of Skin Allograft Rejection: An In Vivo Model of Immune-Mediated Tissue Destruction
Rosenberg, A. S., & Singer, A. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002001 · Cited by 293
Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus
Liu, M. ‐., Wang, C. ‐., Fung, L. ‐., & Wu, C. ‐. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01370.x · Cited by 282
Godfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood-2004-01-0151 · Cited by 277
Self-citationWhere CD4 + CD25 + T reg cells impinge on autoimmune diabetes
Chen, Z., Herman, A. E., Matos, M., Mathis, D., & Benoist, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051409 · Cited by 268
Suhoski, M. M., Golovina, T. N., Aqui, N. A., Tai, V. C., Varela-Rohena, A., Milone, M. C., Carroll, R. G., Riley, J. L., & June, C. H. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300134 · Cited by 266
Self-citationHuman regulatory T cells and their role in autoimmune disease
Baecher‐Allan, C., & Hafler, D. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00417.x · Cited by 266
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M., Der, S. D., Kang, J., & Chambers, C. A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081811 · Cited by 266
Principles of adoptive T cell cancer therapy
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31446 · Cited by 261
Self-citationHori, S., Haury, M., Coutinho, A., & Demengeot, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122224799 · Cited by 258
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Brusko, T., Wasserfall, C., McGrail, K., Schatz, R., Viener, H. L., Schatz, D., Haller, M., Rockell, J., Gottlieb, P., Clare-Salzler, M., et al. (2007) · Diabetes · doi:10.2337/db06-1248 · Cited by 253
Haas, J., Fritzsching, B., Trübswetter, P., Korporal, M., Milkova, L., Fritz, B., Vobis, D., Krammer, P. H., Suri-Payer, E., & Wildemann, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1322 · Cited by 249
A Disquisition on Suppressor T Cells
Gershon, R. K. (1975) · Immunological Reviews · doi:10.1111/j.1600-065x.1975.tb00179.x · Cited by 249
Regulatory T cells in patients with systemic lupus erythematosus
Alvarado-Sánchez, B., Hernández-Castro, B., Portales-Pérez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, A. C., & González-Amaro, R. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.06.005 · Cited by 246
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
Varela-Rohena, A., Molloy, P. E., Dunn, S. M., Li, Y., Suhoski, M. M., Carroll, R. G., Milicic, A., Mahon, T., Sutton, D. H., Laugel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1779 · Cited by 243
Self-citationBeyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203 · cited 1×
“Preclinical data in animal models demonstrated that this Ab preferentially activated Treg cells, and it was thus postulated that TGN1412 could restore tolerance and enable transplants (Beyersdorf et al., 2005; Lin and Hunig, 2003).”
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
Anderson, B. E., McNiff, J. M., Matte, C., Athanasiadis, I., Shlomchik, W. D., & Shlomchik, M. J. (2004) · Blood · doi:10.1182/blood-2004-01-0328 · Cited by 202
Wang, Y., Kissenpfennig, A., Mingueneau, M., Richelme, S., Perrin, P., Chevrier, S., Genton, C., Lucas, B., DiSanto, J. P., Acha-Orbea, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1565 · Cited by 189
α1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice
Lewis, E. C., Mizrahi, M., Toledano, M., DeFelice, N., Wright, J. L., Churg, A., Shapiro, L., & Dinarello, C. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807627105 · Cited by 188
In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation
Earle, K. E., Tang, Q., Zhou, X., Liu, W., Zhu, S., Bonyhadi, M. L., & Bluestone, J. A. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.017 · Cited by 185
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
Lin, C., & Hünig, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200323570 · Cited by 184
Lepault, F., & Gagnerault, M. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.240 · Cited by 183
Basu, S., Golovina, T., Mikheeva, T., June, C. H., & Riley, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5794 · Cited by 183
Self-citationNemunaitis, J., Jahan, T., Ross, H., Sterman, D., Richards, D., Fox, B., Jablons, D., Aimi, J., Lin, A., & Hege, K. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700922 · Cited by 180
CTLA‐4: a key regulatory point in the control of autoimmune disease
Scalapino, K. J., & Daikh, D. I. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00639.x · Cited by 176
Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance
Sánchez-Fueyo, A., Weber, M., Domenig, C., Strom, T. B., & Zheng, X. X. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2274 · Cited by 173
Hanash, A. M., & Levy, R. B. (2005) · Blood · doi:10.1182/blood-2004-08-3213 · Cited by 173
Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.049 · Cited by 168
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice
Koulmanda, M., Bhasin, M., Hoffman, L., Fan, Z., Qipo, A., Shi, H., Bonner-Weir, S., Putheti, P., Degauque, N., Libermann, T. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808031105 · Cited by 165
CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R., Balcarcel, R. R., Fisher, N., Levine, B. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2855 · Cited by 164
Self-citationInduction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes
Joffre, O., Gorsse, N., Romagnoli, P., Hudrisier, D., & van Meerwijk, J. P. M. (2004) · Blood · doi:10.1182/blood-2004-01-0005 · Cited by 163
de Keere, F. V., & Tonegawa, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1875 · Cited by 157
In vivo–activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
Zhao, D., Zhang, C., Yi, T., Lin, C.-L. V., Todorov, I., KANDEEL, F. R., Forman, S. J., & Zeng, D. (2008) · Blood · doi:10.1182/blood-2008-02-140277 · Cited by 151
Hippen, K. L., Harker-Murray, P. D., Porter, S. B., Merkel, S. C., Londer, A., Taylor, D. K., Bina, M., Panoskaltsis‐Mortari, A., Rubinstein, P., van Rooijen, N., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132951 · Cited by 144
Self-citationClinical application of expanded CD4+25+ cells.
June, C., & Blazar, B. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.006 · Cited by 118
Self-citationAnimal models of human type 1 diabetes
von Herrath, M., & Nepom, G. T. (2009) · Nature Immunology · doi:10.1038/ni0209-129 · Cited by 117
Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes
Mekala, D. J., & Geiger, T. L. (2004) · Blood · doi:10.1182/blood-2004-09-3579 · Cited by 103
Li, X., Li, X.-P., Qian, L., Wang, G., Zhang, H., Wang, X., Chen, K., Zhai, Z., Li, Q., Wang, Y., et al. (2007) · PubMed · Cited by 96
Christen, U., & von Herrath, M. G. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.002 · Cited by 80
Glisic-Milosavljevic, S., Waukau, J., Jailwala, P., Jana, S., KHOO, H., Albertz, H., Woodliff, J. E., Koppen, M., Alemzadeh, R., Hagopian, W., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000146 · Cited by 77
CD4+ CD45RB Low-Density Cells from Untreated Mice Prevent Acute Allograft Rejection
Davies, J. D., O’Connor, E., Hall, D. S., Krahl, T., Trotter, J., & Sarvetnick, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5353 · Cited by 73
Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome
Liu, M.-F., Lin, L. H., Weng, C.-T., & Weng, M. (2007) · Lupus · doi:10.1177/0961203307085248 · Cited by 72
CD28 Superagonists: What Makes the Difference in Humans?
Schraven, B. L., & Kalinke, U. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.003 · Cited by 63
Beyersdorf, N., Hanke, T., Kerkau, T., & Hünig, T. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.06.001 · Cited by 61
In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells ExpressingFoxp3
Lundsgaard, D., Holm, T. L., Hornum, L., & Markholst, H. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1040 · Cited by 58
CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance
Jarvinen, L. Z., Blazar, B. R., Adeyi, O. A., Strom, T. B., & Noelle, R. J. (2003) · Transplantation · doi:10.1097/01.tp.0000093462.16309.73 · Cited by 55
Self-citationRicher, M. J., Straka, N., Fang, D., Shanina, I., & Horwitz, M. S. (2008) · Diabetes · doi:10.2337/db07-1460 · Cited by 44
Anderson, A. R., Martens, C. L., Hendrix, R. C., Stempora, L., Miller, W. P., Hamby, K., Russell, M. C., Strobert, E. A., Blazar, B. R., Pearson, T. C., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02376.x · Cited by 28
Self-citationCharacterization of Naturally Occurring CD4+CD25+ Regulatory T Cells in Rhesus Monkeys
Haanstra, K. G., van der Maas, M., Hart, B. A. ‘., & Jonker, M. (2008) · Transplantation · doi:10.1097/tp.0b013e31816b15b9 · Cited by 16
Cited by
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900747 · Cited by 590
Induced CD4+Foxp3+Regulatory T Cells in Immune Tolerance
Bilate, A. M., & Lafaille, J. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075043 · Cited by 569
Nie, H., Zheng, Y., Li, R., Guo, T. B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3085 · Cited by 515
The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells
Amarnath, S., Mangus, C. W., Wang, J. C. M., Wei, F., He, A., Kapoor, V., Foley, J. E., Massey, P. R., Felizardo, T. C., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003130 · Cited by 446
Self-citationPlasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmüller, U., Baron, U., Olek, S., Bluestone, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003099 · Cited by 428
Metadata
- Authors
- Riley, J. L., June, C. H., & Blazar, B. R.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 30
- Issue
- 5
- Pages
- 656-665
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2160700813
- Cited by
- 412
- References
- 130
- FWCI
- 22.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.